Stock Price
6,320.00
Daily Change
-42.00 -0.66%
Monthly
12.86%
Yearly
-6.37%
Q3 Forecast
6,231.08

Teva Pharmaceutical Industries reported $3.28B in Operating Expenses for its fiscal quarter ending in June of 2025.




Operating Expenses Change Date
Aspen Pharmacare ZAR 17.18B 2.89B Dec/2024
Cipla INR 54.32B 687.8M Jun/2025
Dr.Reddys Laboratories INR 67.98B 1.88B Jun/2025
Guangzhou Baiy CNY 18.49B 1.73B Jun/2025
Jiangsu Hengrui CNY 5.69B 570M Jun/2025
Kalbe Farma IDR 7.17T 125.11B Jun/2025
Richter Gedeon HUF 153.02B 2.72B Sep/2024
Sh Fosun Pharma CNY 9.31B 1.25B Jun/2025
Sun Pharmaceuticals INR 104.14B 1.45B Jun/2025
Teva Pharmaceutical Industries USD 3.28B 95M Jun/2025